Perseus Capital

BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.

Metamark Genetics, Inc. is a life science company focused on developing prognostic and predictive diagnostic tests to facilitate personalized treatment planning for cancer patients. Founded in November 2007, the company aims to transform cancer diagnosis and treatment with its Prognosis Determinants™ Platform, which is based on pioneering research in melanoma. These Prognosis Determinants™ are functionally validated genetic elements that play a crucial role in cancer progression across various major cancer types, particularly those that drive metastasis and correlate with poor outcomes. The company's advanced proteomics platform enhances the diagnostic and therapeutic journey for prostate cancer patients by providing sensitive and accurate predictions of progression risk at early disease stages. This technology addresses tumor heterogeneity and enables fully automated, digitalized tissue analyses, allowing patients and their healthcare providers to make informed treatment decisions that improve quality of life and reduce healthcare costs.

CeNeRx BioPharma, Inc., a drug development company, engages in identifying, developing, and commercializing therapeutics to treat diseases related to neurotransmitters and the nervous system. The company's product pipeline includes Tyrima, CX2614, and CX009, which are reversible inhibitors of monoamine oxidase- A that are used for the treatment of mood, anxiety, and somatic disorders. It focuses on developing therapeutics to treat diseases related to neurotransmitters, including anxiety, bipolar disorder, dementia, depression, epilepsy, neuropathic pain, schizophrenia, and Parkinson's and Alzheimer's diseases. The company was founded in 2005 and is based in Cary, North Carolina.

Cymbet Corporation specializes in designing and manufacturing eco-friendly, biocompatible rechargeable solid-state batteries for microelectronic systems. Founded in 2000 and based in Elk River, Minnesota, the company provides innovative energy storage solutions, including its EnerChip batteries, which cater to various industries such as medical, industrial control, telecommunications, and the Internet of Things. Cymbet's products are characterized by their low self-discharge rates and environmentally friendly composition, allowing for easy disposal and integration into electronic devices. The company also offers power management components and evaluation kits to assist electronics designers in expediting product development. Cymbet markets its products through a network of local sales representatives and global distributors, ensuring a wide reach across multiple sectors.

Lumexis Corporation specializes in the development, manufacturing, and marketing of fiber-to-the-screen (FTTS) in-flight entertainment (IFE) and communication systems. Founded in 2003 and based in Costa Mesa, California, the company offers a solution that is lighter and more reliable than traditional embedded IFE systems, resulting in lower maintenance costs. Lumexis's technology allows passengers to utilize multiple screens simultaneously at their seats without interrupting the high-definition content displayed on their monitors. In addition to its innovative systems, Lumexis provides customer support, training, and software services to enhance the user experience.

BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.

BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.

SoftSwitching Technologies specializes in power quality and monitoring solutions tailored for industries such as semiconductor, food, beverage, and automotive. The company provides a range of products, including battery-free DySC systems, intelligent I-Sense sensors that detect the timing and duration of voltage sags, and Grid Alert event notifications, which are part of a global power reporting network. Their offerings are designed to identify and mitigate brief power disruptions, thereby enhancing operational uptime and efficiency in manufacturing processes. Overall, SoftSwitching Technologies aims to deliver effective and scalable solutions that address the critical power quality needs of various sectors.

VPG is working with General Motors through its on-highway integrator Powertrain Integration LLC. Marketing, technical, and infra-structure logistical support for the CNG model will be provided by Clean Energy Fuels Corp., founded by T. Boone Pickens, both of whom are also investors in VPG. The vehicle will be assembled by AM General LLC, in Mishawaka, Indiana, and will employ a classic front-engine, rear-wheel drive architecture which includes a durable body-on-frame structure. Vehicle access is compliant with the vehicle requirements of the Americans with Disabilities Act ("ADA"). The vehicle includes an integrated automatic ramp that will provide quick and easy access for individuals who use wheelchairs, motorized scooters and other mobility devices. Originally introduced as the "Standard Taxi", VPG's vehicle has undergone design and functional enhancements based on input from the marketplace.

Bioenvision a biopharmaceutical company, engages in the acquisition, development, and marketing of compounds and technologies primarily for the treatment of cancer. Its lead products include Evoltra (clofarabine) which has marketing approval in both the European Union and United States for the treatment of pediatric relapsed or refractory acute lymphoblastic leukemia and Modrenal (trilostane), which has marketing approval in the United Kingdom for the treatment of post-menopausal breast cancer following relapse to initial hormone therapy.

Ascenta Therapeutics is a privately-held, clinical stage biopharmaceutical company dedicated to the discovery and development of new medicines to treat cancer. Ascenta's current focus is a portfolio of novel, orally-active, small molecule drugs that restore the natural potential for cancer cells to undergo cell death (apoptosis).

Map Pharmaceuticals, Inc. is a development-stage company based in Mountain View, California, specializing in the creation of novel inhalation therapies for respiratory and systemic diseases. Founded in 2003, the company is advancing several proprietary product candidates through clinical development. These include Unit Dose Budesonide, aimed at treating pediatric asthma in children aged six months to eight years, and MAP0004, designed for migraine relief. Additionally, Map Pharmaceuticals is developing MAP0005 for adolescent and adult asthma and chronic obstructive pulmonary disease, as well as MAP0001, which targets Type 1 and Type 2 diabetes through pulmonary delivery via its Tempo inhaler. The company's focus is on delivering innovative treatments to improve patient outcomes across various health conditions.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.

Map Pharmaceuticals, Inc. is a development-stage company based in Mountain View, California, specializing in the creation of novel inhalation therapies for respiratory and systemic diseases. Founded in 2003, the company is advancing several proprietary product candidates through clinical development. These include Unit Dose Budesonide, aimed at treating pediatric asthma in children aged six months to eight years, and MAP0004, designed for migraine relief. Additionally, Map Pharmaceuticals is developing MAP0005 for adolescent and adult asthma and chronic obstructive pulmonary disease, as well as MAP0001, which targets Type 1 and Type 2 diabetes through pulmonary delivery via its Tempo inhaler. The company's focus is on delivering innovative treatments to improve patient outcomes across various health conditions.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

Iridian Technologies, Inc. specializes in the research, development, and marketing of biometric identification solutions, focusing primarily on iris recognition technology. The company offers PrivateID, an image processing protocol that enables certified iris cameras to capture and process images for secure transport. Additionally, it provides the KnoWho authentication server and related developer tools, along with hardware and software certification programs. Iridian's products are designed to enhance security in various public applications, including passenger travel, border control, national identification, and election verification. The company distributes its authentication server software through integrators and application partners, catering to sectors that require reliable identity verification. Founded in 1990 and based in Moorestown, New Jersey, Iridian Technologies was previously known as IriScan, Inc. before rebranding in 2000.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

Evergreen Solar, Inc. specializes in the development, manufacturing, and marketing of solar power products, specifically photovoltaic modules. The company employs its proprietary STRING RIBBON™ technology, which uses significantly less polysilicon compared to traditional methods, thereby reducing manufacturing costs and material usage. This innovative approach allows Evergreen Solar to produce reliable and environmentally friendly electric power solutions for both residential and commercial applications worldwide. By focusing on low-cost production and international market penetration, Evergreen Solar enables customers to effectively harness solar energy for various power needs, catering to remote and emerging grid-connected markets.

SoftSwitching Technologies specializes in power quality and monitoring solutions tailored for industries such as semiconductor, food, beverage, and automotive. The company provides a range of products, including battery-free DySC systems, intelligent I-Sense sensors that detect the timing and duration of voltage sags, and Grid Alert event notifications, which are part of a global power reporting network. Their offerings are designed to identify and mitigate brief power disruptions, thereby enhancing operational uptime and efficiency in manufacturing processes. Overall, SoftSwitching Technologies aims to deliver effective and scalable solutions that address the critical power quality needs of various sectors.

Encorp is a provider of network technology and infrastructure management services focused on the distributed energy market. The company specializes in energy automation software and grid-interconnection equipment that facilitate the control of various power resources, including engine-generator sets, microturbines, fuel cells, combined heat and power systems, and energy storage devices. By harnessing its advanced Gold Box technology, Encorp enables federal, institutional, and commercial clients to enhance energy savings, security, and efficiency. Its solutions aim to transform the electric grid into a cleaner, more cost-effective, and resilient system. This integration of diverse energy resources is essential for enterprises requiring high-quality, reliable power at predictable costs, while also contributing to the reduction of carbon emissions.

Biometric Access Company (BAC) provides innovative yet practical system solutions that improve data management and transaction processing. Optional ID verification is available through our advanced biometric technologies. BAC is committed to price/performance leadership and the development of superior hardware, software and total system solutions that offer an outstanding return on investment to our customers. As the sole proprietor of our SecureTouch® products, BAC designs, develops, manufactures and markets several hardware and software applications to provide complete user solutions.

Serveron Corporation is a developer of online transformer products and diagnostic services, headquartered in Hillsboro, Oregon. The company specializes in transformer monitors that deliver essential asset data, including dissolved gas analysis of insulating oil in power transformers and other oil-filled equipment. Serveron’s offerings include monitoring services that allow access to transformer data from any Internet-connected Windows personal computer, transformer bushing monitors for power factor testing, and advisory services to help utilities manage their transformer fleets effectively. Additionally, the company provides energy asset management solutions for remote energy systems, enabling real-time monitoring, control, and reporting. Serveron serves a diverse clientele that includes utilities, industrial users, and service organizations both in the United States and internationally. The company was previously known as Micromonitors, Inc. and is currently a subsidiary of BPL Global, Ltd.

ClubMom is a free national membership organization for mothers. It was founded in 1999 and is headquartered in New York.